Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917
- PMID: 15292145
- PMCID: PMC490877
- DOI: 10.1128/JB.186.16.5432-5441.2004
Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917
Abstract
Nonpathogenic Escherichia coli strain Nissle 1917 (O6:K5:H1) is used as a probiotic agent in medicine, mainly for the treatment of various gastroenterological diseases. To gain insight on the genetic level into its properties of colonization and commensalism, this strain's genome structure has been analyzed by three approaches: (i) sequence context screening of tRNA genes as a potential indication of chromosomal integration of horizontally acquired DNA, (ii) sequence analysis of 280 kb of genomic islands (GEIs) coding for important fitness factors, and (iii) comparison of Nissle 1917 genome content with that of other E. coli strains by DNA-DNA hybridization. PCR-based screening of 324 nonpathogenic and pathogenic E. coli isolates of different origins revealed that some chromosomal regions are frequently detectable in nonpathogenic E. coli and also among extraintestinal and intestinal pathogenic strains. Many known fitness factor determinants of strain Nissle 1917 are localized on four GEIs which have been partially sequenced and analyzed. Comparison of these data with the available knowledge of the genome structure of E. coli K-12 strain MG1655 and of uropathogenic E. coli O6 strains CFT073 and 536 revealed structural similarities on the genomic level, especially between the E. coli O6 strains. The lack of defined virulence factors (i.e., alpha-hemolysin, P-fimbrial adhesins, and the semirough lipopolysaccharide phenotype) combined with the expression of fitness factors such as microcins, different iron uptake systems, adhesins, and proteases, which may support its survival and successful colonization of the human gut, most likely contributes to the probiotic character of E. coli strain Nissle 1917.
Figures





Similar articles
-
Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data.J Biotechnol. 2005 May 4;117(2):147-61. doi: 10.1016/j.jbiotec.2005.01.008. J Biotechnol. 2005. PMID: 15823404
-
How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains.Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12879-84. doi: 10.1073/pnas.0603038103. Epub 2006 Aug 15. Proc Natl Acad Sci U S A. 2006. PMID: 16912116 Free PMC article.
-
A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917.J Bacteriol. 2002 Nov;184(21):5912-25. doi: 10.1128/JB.184.21.5912-5925.2002. J Bacteriol. 2002. PMID: 12374825 Free PMC article.
-
(Patho-)Genomics of Escherichia coli.Int J Med Microbiol. 2005 Oct;295(6-7):357-71. doi: 10.1016/j.ijmm.2005.07.009. Int J Med Microbiol. 2005. PMID: 16238013 Review.
-
[Uropathogenic Escherichia coli--ExPEC pathotype, the best characterized].Bacteriol Virusol Parazitol Epidemiol. 2003 Jan-Mar;48(1):31-6. Bacteriol Virusol Parazitol Epidemiol. 2003. PMID: 15214194 Review. Romanian.
Cited by
-
Oxygen-Dependent Cell-to-Cell Variability in the Output of the Escherichia coli Tor Phosphorelay.J Bacteriol. 2015 Jun 15;197(12):1976-87. doi: 10.1128/JB.00074-15. Epub 2015 Mar 30. J Bacteriol. 2015. PMID: 25825431 Free PMC article.
-
A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.Int J Colorectal Dis. 2012 Apr;27(4):467-74. doi: 10.1007/s00384-011-1363-9. Epub 2011 Dec 2. Int J Colorectal Dis. 2012. PMID: 22130826 Free PMC article. Clinical Trial.
-
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.World J Gastroenterol. 2016 Jun 28;22(24):5505-11. doi: 10.3748/wjg.v22.i24.5505. World J Gastroenterol. 2016. PMID: 27350728 Free PMC article. Review.
-
Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.Methods Mol Biol. 2016;1403:363-83. doi: 10.1007/978-1-4939-3387-7_19. Methods Mol Biol. 2016. PMID: 27076141 Free PMC article.
-
Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis.Sci Rep. 2016 Sep 30;6:31152. doi: 10.1038/srep31152. Sci Rep. 2016. PMID: 27686530 Free PMC article.
References
-
- Appelmelk, B. J., Y. Q. An, T. A. Hekker, L. G. Thijs, D. M. MacLaren, and J. de Graaf. 1994. Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients. Microbiology 140:1119-1124. - PubMed
-
- Bettelheim, K. A. 1997. Escherichia coli in the normal flora of humans and animals, p. 85-109. In M. Sussman (ed.), Escherichia coli—Mechanism of virulence. Cambridge University Press, Cambridge, England.
-
- Blattner, F. R., G. Plunkett III, C. A. Bloch, N. T. Perna, V. Burland, M. Riley, J. Collado-Vides, J. D. Glasner, C. K. Rode, G. F. Mayhew, J. Gregor, N. W. Davis, H. A. Kirkpatrick, M. A. Goeden, D. J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials